This Article Full Text Full Text (PDF) Submit a related Letter to the Editor Purchase Article View Shopping Cart Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Carlsson, P.-O. Articles by Mattsson, G. Search for Related Content PubMed PubMed Citation Articles by Carlsson, P.-O. Articles by Mattsson, G.

Low Revascularization of Experimentally Transplanted Human Pancreatic Islets

Departments of Medical Cell Biology (P.-O.C., F.P., G.M.) and Diagnostic Radiology (F.P.), Uppsala University, SE-751 23 Uppsala, Sweden

Address all correspondence and requests for reprints to: Per-Ola Carlsson, M.D., Ph.D., Department of Medical Cell Biology, Biomedical Center, Husargatan 3, Box 571, SE-751 23 Uppsala, Sweden. E-mail: per-ola.carlsson{at}medcellbiol.uu.se.

Abstract

Pancreatic islets are avascular immediately after transplantation. Although the islets are rapidly revascularized, it is uncertain whether the revascularization produces an adequate oxygenation of the transplanted islet tissue. We measured pO₂, blood flow and vascular density in mouse or human islets 1 month after transplantation to nude mice. Tissue pO₂ was measured with Clark microelectrodes. Blood perfusion was measured with laser-Doppler flow cytometry, whereas vascular density was determined in histological specimens stained for the lectin Bandeiraea simplicifolia (BS-1). Both the transplanted mouse and human islets had a pO₂ 15–20% of that in endogenous mouse islets. Moreover, the vascular density of the transplanted islets was decreased compared with that of endogenous mouse and human islets. Graft blood perfusion was approximately 50% of renal cortex blood flow. A negative correlation was found between donor age and blood perfusion of the human islet grafts. A similar correlation was seen between donor age and the total vascular density of these grafts. In conclusion, transplanted human islets had a markedly decreased vascular density and pO₂ compared with endogenous islets. This has potential implications for clinical islet transplantations, because poor vascular engraftment may significantly increase the number of islets needed to obtain insulin independence.

This article has been cited by other articles:

				X. Huang, D. J. Moore, R. J. Ketchum, C. S. Nunemaker, B. Kovatchev, A. L. McCall, and K. L. Brayman Resolving the Conundrum of Islet Transplantation by Linking Metabolic Dysregulation, Inflammation, and Immune Regulation Endocr. Rev., August 1, 2008; 29(5): 603 - 630. [Abstract] [Full Text] [PDF]

				J. Olerud, M. Johansson, J. Lawler, N. Welsh, and P.-O. Carlsson Improved Vascular Engraftment and Graft Function After Inhibition of the Angiostatic Factor Thrombospondin-1 in Mouse Pancreatic Islets Diabetes, July 1, 2008; 57(7): 1870 - 1877. [Abstract] [Full Text] [PDF]

				J. A. Emamaullee, J. Davis, R. Pawlick, C. Toso, S. Merani, S.-X. Cai, B. Tseng, and A.M. J. Shapiro The Caspase Selective Inhibitor EP1013 Augments Human Islet Graft Function and Longevity in Marginal Mass Islet Transplantation in Mice Diabetes, June 1, 2008; 57(6): 1556 - 1566. [Abstract] [Full Text] [PDF]

				A. J.F. King, J. R. Fernandes, J. Hollister-Lock, C. E. Nienaber, S. Bonner-Weir, and G. C. Weir Normal Relationship of {beta}- and Non {beta}-Cells Not Needed for Successful Islet Transplantation Diabetes, September 1, 2007; 56(9): 2312 - 2318. [Abstract] [Full Text] [PDF]

				J. A. Emamaullee, L. Stanton, C. Schur, and A.M. J. Shapiro Caspase Inhibitor Therapy Enhances Marginal Mass Islet Graft Survival and Preserves Long-Term Function in Islet Transplantation Diabetes, May 1, 2007; 56(5): 1289 - 1298. [Abstract] [Full Text] [PDF]

				J. Gromada, I. Franklin, and C. B. Wollheim {alpha}-Cells of the Endocrine Pancreas: 35 Years of Research but the Enigma Remains Endocr. Rev., February 1, 2007; 28(1): 84 - 116. [Abstract] [Full Text] [PDF]

				J. A. Emamaullee and A.M. J. Shapiro Interventional Strategies to Prevent {beta}-Cell Apoptosis in Islet Transplantation. Diabetes, July 1, 2006; 55(7): 1907 - 1914. [Abstract] [Full Text] [PDF]

				M. Brissova, M. Fowler, P. Wiebe, A. Shostak, M. Shiota, A. Radhika, P. C. Lin, M. Gannon, and A. C. Powers Intraislet Endothelial Cells Contribute to Revascularization of Transplanted Pancreatic Islets Diabetes, May 1, 2004; 53(5): 1318 - 1325. [Abstract] [Full Text] [PDF]

				G. Mattsson, L. Jansson, A. Nordin, A. Andersson, and P.-O. Carlsson Evidence of Functional Impairment of Syngeneically Transplanted Mouse Pancreatic Islets Retrieved from the Liver Diabetes, April 1, 2004; 53(4): 948 - 954. [Abstract] [Full Text] [PDF]

				R. P. Robertson Islet Transplantation as a Treatment for Diabetes -- A Work in Progress N. Engl. J. Med., February 12, 2004; 350(7): 694 - 705. [Full Text] [PDF]

				A. Omer, V. F. Duvivier-Kali, W. Aschenbach, V. Tchipashvili, L. J. Goodyear, and G. C. Weir Exercise Induces Hypoglycemia in Rats With Islet Transplantation Diabetes, February 1, 2004; 53(2): 360 - 365. [Abstract] [Full Text]

				V. Mathews, P. T. Hanson, E. Ford, J. Fujita, K. S. Polonsky, and T. A. Graubert Recruitment of Bone Marrow-Derived Endothelial Cells to Sites of Pancreatic {beta}-Cell Injury Diabetes, January 1, 2004; 53(1): 91 - 98. [Abstract] [Full Text] [PDF]

				R. P. Robertson Intrahepatically Transplanted Islets--Strangers in a Strange Land J. Clin. Endocrinol. Metab., December 1, 2002; 87(12): 5416 - 5417. [Full Text] [PDF]